Analysis of public databases indicates that USP35 is frequently amplified in ovarian cancer and expressed at higher levels than in normal cells, but increased levels can be found in other cancer types such as renal cell carcinoma and gastric cancer 99, 100. Here, USP35 is linked to ovarian cancer.